Kineret — CareFirst (Caremark)
Pseudogout flares (calcium pyrophosphate deposition disease)
Initial criteria
- Adult member.
- Member has experienced at least three gout flares in the last 12 months.
- Member has had an inadequate response, intolerance, or contraindication to non-steroidal anti-inflammatory drugs (NSAIDs), colchicine, and corticosteroids.
Approval duration
12 months